Health ❯ Chronic Diseases

Obesity

Diabetes Type 2 Diabetes Dietary Impact Health Risks Treatment Options Weight Management Metabolic Disorders Metabolic Syndrome Heart Disease Hypertension

Boehringer’s Survodutide Cuts Body Weight 16.6% in Phase III Trial

The result strengthens Boehringer’s push to break into a market led by Eli Lilly and Novo Nordisk.

Ultra-Processed Foods Linked to Higher Thigh Muscle Fat in MRI Study

Obesity Before 30 Tied to Much Higher Risk of Early Death, Swedish Study Finds

Study Finds Distinct Cardiometabolic Risks for Men and Women With Obesity

JW Pharmaceutical Licenses Korean Rights to Gan & Lee’s GLP-1 Drug in Deal Worth Up to $81 Million

Monthly Binge Drinking Linked to Triple Risk of Advanced Liver Scarring in MASLD

Ultra-Processed Foods Tied to Sharply Higher Heart Risk in New 12-Year U.S. Study

Roche Expands NVIDIA Partnership, Building Pharma’s Largest Hybrid‑Cloud AI Factory

Mexico Launches 500,000-Person Obesity Study in New National Strategy as Regional Alarms Grow

Eli Lilly Unveils Employer Connect, Offering Zepbound to Employers at a Uniform $449 Net Price

Mexico Launches National Strategy to Slow Obesity on World Obesity Day

World Obesity Day: Diagnoses Climb as Policy Momentum Builds and Services Scale Up

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

Global Study Ties Ultra-Processed Foods to Youth Mental Declines as India Weighs Action

Brazil Weighs Tirzepatide Access: New Bill Seeks Farmácia Popular Coverage as Patent‑Break Push Advances

Louisiana Begins SNAP Ban on Soda, Energy Drinks and Candy

Medical and Consumer Groups Press CDU to Back Sugar Levy on Soft Drinks

Study Finds Most U.S. Baby Foods Are Ultra‑Processed as HHS Moves to Review GRAS

Pitt Study Identifies SerpinB2 as Key to Protective Fat Macrophages, Pointing to a New Diabetes Treatment Path

Experts Flag Nutrition Risks With GLP-1 Weight-Loss Drugs